Compare ZUMZ & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZUMZ | AGL |
|---|---|---|
| Founded | 1978 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.7M | 422.9M |
| IPO Year | 2005 | 2021 |
| Metric | ZUMZ | AGL |
|---|---|---|
| Price | $21.77 | $0.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 14 |
| Target Price | ★ $18.00 | $2.66 |
| AVG Volume (30 Days) | 177.1K | ★ 5.5M |
| Earning Date | 06-11-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | $929,057,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $6.33 | N/A |
| Revenue Next Year | $1.90 | $7.17 |
| P/E Ratio | $27.47 | ★ N/A |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $11.31 | $0.34 |
| 52 Week High | $31.70 | $6.08 |
| Indicator | ZUMZ | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 50.23 |
| Support Level | $21.48 | $0.51 |
| Resistance Level | $22.96 | $0.73 |
| Average True Range (ATR) | 1.34 | 0.08 |
| MACD | -0.35 | 0.02 |
| Stochastic Oscillator | 24.85 | 62.20 |
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.